FMO5 and chronic granulomatous disease: These studies were extended to human cell lines, where retroviral vectors to restore NADPH oxidase activity was tested in human myeloid leukemic cell lines defective in superoxide production, as well as in primary CD34+ cells obtained from X-CGD patients.